SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 13th, 2024 • iTeos Therapeutics, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledMay 13th, 2024 Company Industry JurisdictionThis SECURITIES PURCHASE AGREEMENT (this “Agreement”) is dated as of May 10, 2024, by and among iTeos Therapeutics, Inc., a Delaware corporation (the “Company”), and each of the entities listed on Exhibit A attached to this Agreement (each, including its successors and assigns, an “Investor” and together, the “Investors”).